Skip to content

Post-prandial Glucose in Healthy Subjects

Effect of Different Levels of Plant-based Ingredients on Post-prandial Glucose in Healthy Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01955447
Enrollment
84
Registered
2013-10-07
Start date
2013-11-30
Completion date
Unknown
Last updated
2014-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subjects

Keywords

Blood glucose

Brief summary

The study is designed to determine the extent to which foods containing different levels of plant-based ingredients affect blood glucose responses in healthy subjects.

Interventions

DIETARY_SUPPLEMENTno added plant-based ingredients to starchy meal

no added plant-based ingredients to starchy meal

DIETARY_SUPPLEMENTLow level plant-based ingredients added to starchy meal

Low level plant-based ingredients added to starchy meal

DIETARY_SUPPLEMENTMedium level plant-based ingredients added to starchy meal

Medium level plant-based ingredients added to starchy meal

DIETARY_SUPPLEMENTHigh level plant-based ingredients added to starchy meal

High level plant-based ingredients added to starchy meal

Sponsors

Unilever R&D
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Willing to give consent to participate in the study in writing; * Healthy male and female subjects, between the age of ≥20 and ≤50 yrs of age at first screening visit; * Body Mass Index (BMI) between ≥18 and ≤ 25 kg/m2; * Apparently healthy: no medical conditions which might affect study measurement, as judged by study physician and/or measured by questionnaire, and/or assessed by haematology, blood chemistry and urinalysis; * Willing to comply to study protocol during the study; * Agreeing to be informed about medically relevant personal test-results by study physician; * Willing to refrain from drinking of alcohol on and one day before the blood withdrawal; * Fasting blood glucose value of volunteer is ≥ 3.4 and ≤ 6.1 mmol/litre (i.e. 62-110 mg/dl) at screening; * Haemoglobin level within clinically acceptable range (for male 12 to 17 gm/dL and for females 11 to 15 gm / dL; both inclusive) as judged by the research physician.

Exclusion criteria

* Being an employee of Unilever or CRO; * Chronic smokers, tobacco chewers and drinkers; * Participation in any other biomedical study 3 months before screening visit day of this study and/or participating in any other biomedical study during the screening period; * Use of medication which interferes with study measurements including vitamins, tonics; * Reported intense exercise ≥10 h/week; * Reported weight loss/gain ≥ 10% of body weight in the 6 months preceding screening * Blood donation for 2 months prior to screening; * Urine analysis that showed any drug abuse; * Allergy to any food or cosmetics; * If female, not being pregnant or planning pregnancy during the study period; * If female, lactating or has been lactating for 6 weeks before pre-study investigation and/or during the study period.

Design outcomes

Primary

MeasureTime frame
Post-prandial blood glucose area under the curve120 minutes

Secondary

MeasureTime frame
Post-prandial insulin area under the curve120 minutes

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026